Yang Zhao

Yang Zhao


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Molecular Immunology
Verified
Journal Article
Closed access
LZLin Zhou
Lin Zhou
HLHan Li
Han Li
XZXin-Xue Zhang
Xin-Xue Zhang
YZYang Zhao
Yang Zhao
JWJing Wang
Jing Wang
XLXianliang Li
Xianliang Li

17 April 2026 in Hepatology Communications
Verified
Journal Article
Open access
LZLin Zhou
Lin Zhou
YZYang Zhao
Yang Zhao
JWJing Wang
Jing Wang
QCQing Chen
Qing Chen
YJYa-Nan Jia
Ya-Nan Jia
GDGuosheng Du
Guosheng Du
Background: Inducing transplant tolerance to achieve long-term graft survival without immunosuppression remains a central objective in liver transplantation. Methods: Using a rat liver transplantation model, we evaluated the effects of infusing rapamycin-modified tolerogenic dendritic cells (Rapa-tolDCs) on graft survival and tolerance induction. Underlying molecular and cellular mechanisms were investigated through activation and inhibition experiments to assess the generation, signaling pathways, and suppressive functions of regulatory T and B cell populations. Results: Infusion of Rapa-tolDCs induced donor-specific tolerance and markedly prolonged graft survival (median survival time of 65 days, maximum of 102 days). Mechanistically, Rapa-tolDCs, characterized by low expression of Siglec1 and Spp1, functioned independently of the PI3K–mTOR pathway and promoted the differentiation and proliferation of CD8+CD45RClow/− regulatory T cells (CD8+CD45RClow/− Tregs). We identified that these Tregs acquired MHC-II molecules from donor cells via trogocytosis, becoming immune chimeric cells that predominantly secreted interleukin-10 (IL-10) to mediate immune suppression. The generation of these MHC-II+CD8+ Tregs was regulated by the Wnt5a/Fzd4/RhoD signaling axis. Furthermore, elevated levels of Foxp3+ Tregs and IL-10+ Bregs were found to contribute to prolonged graft survival following Rapa-tolDC infusion. Conclusions: These findings delineate a complete mechanistic pathway from cell therapy to donor-specific tolerance and provide a foundational strategy for clinical tolerance induction and post-transplant immunomodulation.